Advertisement

Topics

Transgenomic Prepares for Planned Relisting On NASDAQ

07:30 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Transgenomic Inc. (OTCQB:TBIOD) today announced that it is advancing its previously announced plans for relisting on the NASDAQ Capital Market. After receiving shareholder approval, the company implemented a reverse split of its...

Other Sources for this Article

Transgenomic
Media:
Barbara Lindheim, 212-584-2276
BLL Partners
blindheim@bllbiopartners.com
or
Investors:
Transgenomic Investor Relations
investor.relations@transgenomic.com

NEXT ARTICLE

More From BioPortfolio on "Transgenomic Prepares for Planned Relisting On NASDAQ"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...